What is palisadebio?
Palisade Bio, Inc. operates as a clinical-stage biotechnology enterprise dedicated to the discovery and development of innovative therapeutic candidates. The company focuses on addressing significant unmet medical needs in the realms of autoimmune, inflammatory, and fibrotic diseases. By prioritizing precision medicine, Palisade Bio aims to refine treatment outcomes while mitigating the systemic side effects often associated with traditional pharmacological interventions. Their research-driven business model is designed to translate complex scientific insights into targeted, high-impact therapies for patients suffering from chronic, difficult-to-treat conditions.
How much funding has palisadebio raised?
palisadebio has raised a total of $4.4M across 2 funding rounds:
Stock/Share Issuance
$3.9M
Private Equity
$500K
Stock/Share Issuance (2025): $3.9M, investors not publicly disclosed
Private Equity (2026): $500K led by Crohn's & Colitis Foundation
Key Investors in palisadebio
Crohn's & Colitis Foundation
A non-profit, volunteer-fueled organization dedicated to finding cures for Crohn's disease and ulcerative colitis while improving the quality of life for affected patients.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for palisadebio?
With the recent capital infusion, Palisade Bio is expected to prioritize the advancement of its lead therapeutic candidates through critical clinical trial phases. The strategic allocation of these funds will likely focus on expanding research capabilities and strengthening the company's intellectual property portfolio. As the firm continues to refine its precision medicine platform, stakeholders will be monitoring the progress of its pipeline for potential breakthroughs in inflammatory disease management. The company's ability to execute on its clinical milestones will be the primary determinant of its long-term valuation and market influence in the biotech sector.
See full palisadebio company page
